First Hawaiian Bank’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-57,550
Closed -$2.75M 377
2024
Q4
$2.75M Buy
57,550
+20,700
+56% +$1.06M 0.09% 159
2024
Q3
$2.11M Buy
36,850
+31,279
+561% +$1.79M 0.07% 222
2024
Q2
$292K Buy
5,571
+530
+11% +$23.2K 0.01% 695
2024
Q1
$205K Sell
5,041
-8,810
-64% -$330K 0.01% 743
2023
Q4
$512K Sell
13,851
-2,265
-14% -$85.3K 0.02% 577
2023
Q3
$616K Sell
16,116
-480
-3% -$19.7K 0.02% 509
2023
Q2
$599K Buy
16,596
+51
+0.3% +$1.74K 0.02% 526
2023
Q1
$632K Sell
16,545
-10,740
-39% -$504K 0.02% 514
2022
Q4
$1.55M Sell
27,285
-4,670
-15% -$239K 0.06% 261
2022
Q3
$1.26M Buy
31,955
+3,450
+12% +$152K 0.05% 280
2022
Q2
$1.25M Buy
28,505
+14,885
+109% +$644K 0.05% 293
2022
Q1
$543K Hold
13,620
0.02% 572
2021
Q4
$548K Hold
13,620
0.02% 603
2021
Q3
$554K Buy
+13,620
New +$569K 0.02% 461

Other funds holding HALO

First Hawaiian Bank's HALO Position: Q1 2025 in Review

First Hawaiian Bank sold out of Halozyme (HALO) in Q1 2025, closing a stake of 57,550 shares — an estimated $2.75M sold.

First Hawaiian Bank first reported a position in HALO in Q3 2021 and held it in 14 quarters. The position peaked at $2.75M in Q4 2024. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • First Hawaiian Bank reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 57,550 Halozyme shares in Q1 2025, an estimated $2.75M.
  • First Hawaiian Bank first reported a position in Halozyme in Q3 2021 and held it in 14 quarters.
  • First Hawaiian Bank's Halozyme position peaked at $2.75M in Q4 2024.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.